Wellbutrin contains one active ingredient: bupropion hydrochloride, an antidepressant that belongs to a chemical class called aminoketones. Unlike most other antidepressants, bupropion is chemically unrelated to SSRIs, tricyclics, or any other major antidepressant family. That distinction matters because it works through a different mechanism in the brain and carries a different side effect profile than what most people associate with antidepressants.
The Active Ingredient: Bupropion
Bupropion hydrochloride is the only therapeutic compound in every version of Wellbutrin. It primarily affects two brain chemicals: dopamine and norepinephrine. Most antidepressants target serotonin, but bupropion largely leaves serotonin alone. This is why it’s less likely to cause sexual side effects or weight gain, two complaints that frequently come up with serotonin-based antidepressants.
Once you take it, your liver breaks bupropion down into three active metabolites, meaning the drug itself transforms into other compounds that also have effects in your body. The most significant of these is hydroxybupropion, produced by a liver enzyme called CYP2B6. Two other active metabolites form through a different chemical pathway. These breakdown products are pharmacologically active, which means they contribute to the drug’s overall effect and also influence how bupropion interacts with other medications you might be taking.
Available Forms and Strengths
Wellbutrin comes in three formulations, each designed to release bupropion into your bloodstream at a different speed:
- Wellbutrin IR (immediate-release): Taken two or three times per day, available in 75 mg and 100 mg tablets.
- Wellbutrin SR (sustained-release): Taken twice daily, available in 100 mg, 150 mg, and 200 mg tablets.
- Wellbutrin XL (extended-release): Taken once daily, available in 150 mg and 300 mg tablets.
The active ingredient is identical across all three. The difference is in how the tablet is engineered to dissolve. Extended-release and sustained-release versions use special coatings and binding agents to slow down absorption, which keeps blood levels more stable throughout the day and reduces peak-related side effects.
Inactive Ingredients
Beyond bupropion itself, each tablet contains a list of inactive ingredients that give it structure, help it dissolve properly, and create its coating. For the sustained-release version, these include microcrystalline cellulose (a plant-based filler), magnesium stearate (a lubricant that prevents the tablet from sticking to manufacturing equipment), hypromellose (a coating agent), polyethylene glycol, polysorbate 80, titanium dioxide for color, and copovidone as a binder. Coloring agents like FD&C Blue No. 2 and FD&C Red No. 40 give the tablets their appearance. A flavoring blend containing dextrose, ethyl alcohol, gum arabic, and propylene glycol rounds out the formulation.
These inactive ingredients vary slightly between the IR, SR, and XL versions, and they also differ between brand-name and generic products. If you have sensitivities to dyes or specific compounds, the inactive ingredient list on your specific manufacturer’s product is the one to check.
What It’s Prescribed For
Wellbutrin is FDA-approved for treating major depressive disorder. Under the brand name Zyban, the same active ingredient is approved for smoking cessation. Bupropion also appears in a combination pill with naltrexone (sold as Contrave) for weight management.
Clinicians frequently prescribe bupropion off-label for other conditions. It’s commonly used for attention-deficit/hyperactivity disorder (ADHD), particularly when stimulant medications aren’t appropriate, and there is sufficient evidence supporting its effectiveness in outpatient ADHD treatment. It’s also prescribed off-label for anxiety and as an aid for weight loss, since it’s one of the few antidepressants that tends to be weight-neutral or even associated with modest weight reduction.
Brand-Name vs. Generic: Not Always Identical
Generic bupropion is widely available and, in most cases, works the same as brand-name Wellbutrin. However, the FDA found that not all generics are truly equivalent, particularly at the 300 mg extended-release strength. When generic versions of Wellbutrin XL 300 mg first hit the market, manufacturers had only tested bioequivalence at the 150 mg strength and assumed the results would carry over. The FDA later determined that approach was inadequate.
Specifically, Budeprion XL 300 mg (made by Impax Laboratories and marketed by Teva) failed to release bupropion into the blood at the same rate and extent as Wellbutrin XL 300 mg. A Watson-manufactured generic also lost its equivalence rating. Three other manufacturers, Actavis, Mylan, and Par Pharmaceutical, submitted data confirming their 300 mg generics are therapeutically equivalent. If you’ve switched to a generic and noticed a change in how the medication feels, this history of uneven generic quality is a real, documented explanation.
Seizure Risk and Dose Limits
Bupropion carries a dose-dependent seizure risk that shapes how it’s prescribed. At sustained-release doses up to 300 mg per day, the seizure rate is roughly 0.1%, or about 1 in 1,000 people. For the immediate-release version at doses between 300 and 450 mg per day, that rate climbs to about 0.4%. Between 450 and 600 mg per day, seizure risk jumps nearly tenfold.
This is why Wellbutrin has a hard ceiling on dosing that your prescriber won’t exceed, and why no single dose should be too large. It’s also the reason bupropion is contraindicated for people with seizure disorders, those with a current or past diagnosis of bulimia or anorexia nervosa (eating disorders were linked to higher seizure rates in clinical trials), and anyone going through abrupt withdrawal from alcohol, benzodiazepines, or barbiturates. All of these conditions lower the seizure threshold enough to make bupropion unsafe.